Related Experiment Video
Updated: Jun 10, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
V Brazilian Consensus on Rhinitis - 2024.
Dirceu Solé1, Fábio Chigres Kuschnir2, Antônio Carlos Pastorino3
1Universidade Federal de São Paulo, Escola Paulista de Medicina, São Paulo, SP, Brazil; Sociedade Brasileira de Pediatria, Rio de Janeiro, RJ, Brazil.
The V Brazilian Consensus on Rhinitis provides updated, evidence-based guidelines for diagnosing and managing rhinitis. It emphasizes personalized treatment and integrated care to improve patient quality of life.
Area of Science:
- Allergy and Immunology
- Otorhinolaryngology
- Public Health
Background:
- Significant advancements in understanding rhinitis since the 2017 consensus.
- Rhinitis is a common condition often underestimated, necessitating updated management strategies.
Purpose of the Study:
- To present the V Brazilian Consensus on Rhinitis, unifying evidence-based approaches.
- To improve the diagnosis and treatment of various rhinitis forms.
- To provide healthcare professionals with an updated guide for rhinitis management.
Main Methods:
- Development of a joint guideline by ASBAI, SBP, and SBORL.
- Comprehensive review of rhinitis phenotypes, endotypes, risk factors, and diagnostic criteria.
- Inclusion of clinical and laboratory investigation methods, treatment strategies, and special population considerations.
Main Results:
- Updated definitions and diagnostic criteria for rhinitis.
- Emphasis on personalized treatment considering symptom severity, comorbidities, and quality of life.
- Discussion of pharmacological, non-pharmacological, and immunobiological treatment options.
Conclusions:
- The consensus offers a comprehensive, integrated, and evidence-based approach to rhinitis management.
- Focus on patient education, prevention, and management in specific populations (children, pregnant women, elderly).
- Aims to enhance patient quality of life through improved rhinitis care.
Related Concept Videos
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in...
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Upper Respiratory Drugs: First and Second-Generation Antihistamines
Histamine binds to specific receptor sites, known as H1 receptors, on tissue cells, triggering inflammation and swelling. Antihistamines combat these effects by competing with histamine for these receptor sites. By...
Common Respiratory Disorders
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...

